AUPQ005399A0 - Agonists or antagonists for haemopoietic growth factors - Google Patents
Agonists or antagonists for haemopoietic growth factorsInfo
- Publication number
- AUPQ005399A0 AUPQ005399A0 AUPQ0053A AUPQ005399A AUPQ005399A0 AU PQ005399 A0 AUPQ005399 A0 AU PQ005399A0 AU PQ0053 A AUPQ0053 A AU PQ0053A AU PQ005399 A AUPQ005399 A AU PQ005399A AU PQ005399 A0 AUPQ005399 A0 AU PQ005399A0
- Authority
- AU
- Australia
- Prior art keywords
- agonists
- antagonists
- growth factors
- haemopoietic growth
- haemopoietic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7153—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for colony-stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPQ0053A AUPQ005399A0 (en) | 1999-04-29 | 1999-04-29 | Agonists or antagonists for haemopoietic growth factors |
PCT/AU2000/000394 WO2000066632A1 (en) | 1999-04-29 | 2000-05-01 | Agonists or antagonists for haemopoietic growth factors |
AU40931/00A AU4093100A (en) | 1999-04-29 | 2000-05-01 | Agonists or antagonists for haemopoietic growth factors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPQ0053A AUPQ005399A0 (en) | 1999-04-29 | 1999-04-29 | Agonists or antagonists for haemopoietic growth factors |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPQ005399A0 true AUPQ005399A0 (en) | 1999-05-27 |
Family
ID=3814253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPQ0053A Abandoned AUPQ005399A0 (en) | 1999-04-29 | 1999-04-29 | Agonists or antagonists for haemopoietic growth factors |
Country Status (2)
Country | Link |
---|---|
AU (1) | AUPQ005399A0 (en) |
WO (1) | WO2000066632A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6670150B1 (en) * | 2001-05-10 | 2003-12-30 | Applera Corporation | Isolated human receptor proteins, nucleic acid molecules encoding human receptor proteins, and uses thereof |
US7053050B2 (en) | 2001-11-02 | 2006-05-30 | Yoshiko Yasuda | Preventives/remedies for proliferative organ diseases chronic arthritic diseases, hypertrophic scar or keloid |
US7396913B2 (en) | 2002-10-14 | 2008-07-08 | Abbott Laboratories | Erythropoietin receptor binding antibodies |
AU2004252395A1 (en) * | 2003-06-30 | 2005-01-06 | Biovitrum Ab (Publ) | Methods for identifying agents, which regulate cytokines |
SE0301917D0 (en) | 2003-06-30 | 2003-06-30 | Biovitrum Ab | Methods for identifying active compounds |
US20100260744A1 (en) * | 2007-07-11 | 2010-10-14 | Medvet Science Pty Ltd. | Regulating il-4 and il-13 levels by blocking high affinity binding by il-3, il-5 and gm-csf to their common receptor |
US20100209341A1 (en) | 2009-02-18 | 2010-08-19 | Csl Limited | Treatment of chronic inflammatory conditions |
GB201113354D0 (en) * | 2011-08-03 | 2011-09-21 | Univ Sheffield | Leptin receptor structure |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT83761B (en) * | 1985-11-19 | 1989-06-30 | Schering Biotech Corp | METHOD FOR THE PRODUCTION OF INTERLEUQUIN-4 OF MAMIFERO |
US5516512A (en) * | 1989-08-14 | 1996-05-14 | Gist-Brocades, N.V. | N- and C-terminal truncation and deletion mutants of human interleukin-3 |
AU690128B2 (en) * | 1993-07-28 | 1998-04-23 | Medvet Science Pty. Ltd. | Haemopoietic growth factor antagonists |
AUPN481295A0 (en) * | 1995-08-16 | 1995-09-07 | Medvet Science Pty. Ltd. | Agonists of haemopoietic growth factors |
-
1999
- 1999-04-29 AU AUPQ0053A patent/AUPQ005399A0/en not_active Abandoned
-
2000
- 2000-05-01 WO PCT/AU2000/000394 patent/WO2000066632A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2000066632A1 (en) | 2000-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5203999A (en) | Beta3-adrenergic receptor agonists | |
AU3033500A (en) | Non-peptide glp-1 agonists | |
AU7315800A (en) | Mch antagonists | |
AU3213799A (en) | Integrin antagonists | |
AU1772300A (en) | Glucagon antagonists/inverse agonists | |
EP1058067A3 (en) | Rod holder | |
AU3924300A (en) | Fibroblast growth factor-20 | |
AUPP380498A0 (en) | Egf receptor agonists and antagonists | |
AU2541000A (en) | Beta-phenylalanine derivatives as integrin antagonists | |
AU2576501A (en) | Protein kinase inhibitors | |
AU2441801A (en) | Urotensin-ii receptor antagonists | |
AU3703499A (en) | Substituted indolinones as kinase inhibitors | |
AUPQ005399A0 (en) | Agonists or antagonists for haemopoietic growth factors | |
AU4961499A (en) | 5-HT1f agonists | |
AU3235100A (en) | Prothease inhibitors | |
AU5338699A (en) | Imidazoles and related compounds as alpha1a agonists | |
AU5861900A (en) | Receptor agonists and antagonists | |
AU5706000A (en) | Useful polypeptide | |
AU5914299A (en) | Antagonists of fibroblast growth factor | |
AUPQ084899A0 (en) | Neurotrophin agonists | |
AU1100300A (en) | Piperidyloxadiazoles as dopamine receptor antagonists | |
AU4849199A (en) | Fungal growth inhibitors | |
AU5084600A (en) | Cup holder | |
AUPQ015299A0 (en) | Ph probe | |
AU4093100A (en) | Agonists or antagonists for haemopoietic growth factors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAA1 | Application designating australia and claiming priority from australian document |
Ref document number: 4093100 Country of ref document: AU |